Issue 23, 2015

Reduction-responsive dithiomaleimide-based nanomedicine with high drug loading and FRET-indicated drug release

Abstract

Dithiomaleimide-based camptothecin-containing nanoparticles are designed to have exceptionally high drug loading and are capable of reduction-responsive, FRET-indicated drug release.

Graphical abstract: Reduction-responsive dithiomaleimide-based nanomedicine with high drug loading and FRET-indicated drug release

Supplementary files

Article information

Article type
Communication
Submitted
07 Jan 2015
Accepted
05 Feb 2015
First published
18 Feb 2015

Chem. Commun., 2015,51, 4807-4810

Reduction-responsive dithiomaleimide-based nanomedicine with high drug loading and FRET-indicated drug release

H. Wang, M. Xu, M. Xiong and J. Cheng, Chem. Commun., 2015, 51, 4807 DOI: 10.1039/C5CC00148J

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements